Vicarious Surgical Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters

2024/11/13

* Vicarious Surgical Inc reported a quarterly adjusted loss of $2.90 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-3.00. The mean expectation of four analysts for the quarter was for a loss of $2.55 per share. Wall Street expected results to range from $-2.80 to $-2.29 per share.

* Reported revenue was zero; analysts expected zero.

* Vicarious Surgical Inc's reported EPS for the quarter was a loss of $2.90.

* The company reported a quarterly loss of $17.09 million.

* Vicarious Surgical Inc shares had risen by 96.3% this quarter and gained 1.4% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts was unchanged in the last three months.

* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the advanced medical equipment & technology peer group is also "hold"

Wall Street's median 12-month price target for Vicarious Surgical Inc is 10.00 This summary was machine generated from LSEG data November 12 at 11:27 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 -2.55 -2.90 Missed

Jun. 30 2024 -2.77 -2.59 Beat

Mar. 31 2024 -2.85 -3.00 Missed

Dec. 31 2023 -3.75 -1.80 Beat

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2483062095"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2483062095\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2483062095?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-13 07:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483062095","market":"us","top_or_hot":-1,"title":"Vicarious Surgical Inc reports results for the quarter ended September 30 - Earnings Summary","media":"Reuters","content":"<html><body><p>* Vicarious Surgical Inc    reported a quarterly adjusted loss of $2.90 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-3.00.  The mean expectation of four analysts for the quarter was for a loss of $2.55 per share. Wall Street expected results to range from $-2.80 to $-2.29 per share.</p><p>   * Reported revenue was zero; analysts expected zero. </p><p>   * Vicarious Surgical Inc's reported EPS for the quarter was a loss of $2.90.</p><p>   * The company reported a quarterly loss of $17.09 million.</p><p>   * Vicarious Surgical Inc shares had risen by 96.3% this quarter and gained 1.4% so far this year.</p><p>FORECAST CHANGES</p><p>   * The mean earnings estimate of analysts was unchanged in the last three months. </p><p>   * In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p><p>RECOMMENDATIONS</p><p>   * The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 3 \"hold\" and no \"sell\" or \"strong sell.\" </p><p>   * The average consensus recommendation for the advanced medical equipment &amp; technology peer group is also \"hold\"</p><p>Wall Street's median 12-month price target for Vicarious Surgical Inc is 10.00  This summary was machine generated from LSEG data November 12 at 11:27 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,</p><p>                                                MISSED</p><p>Sep. 30 2024      -2.55          -2.90          Missed</p><p>Jun. 30 2024      -2.77          -2.59          Beat</p><p>Mar. 31 2024      -2.85          -3.00          Missed</p><p>Dec. 31 2023      -3.75          -1.80          Beat</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vicarious Surgical Inc reports results for the quarter ended September 30 - Earnings Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVicarious Surgical Inc reports results for the quarter ended September 30 - Earnings Summary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-11-13 07:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>* Vicarious Surgical Inc    reported a quarterly adjusted loss of $2.90 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-3.00.  The mean expectation of four analysts for the quarter was for a loss of $2.55 per share. Wall Street expected results to range from $-2.80 to $-2.29 per share.</p><p>   * Reported revenue was zero; analysts expected zero. </p><p>   * Vicarious Surgical Inc's reported EPS for the quarter was a loss of $2.90.</p><p>   * The company reported a quarterly loss of $17.09 million.</p><p>   * Vicarious Surgical Inc shares had risen by 96.3% this quarter and gained 1.4% so far this year.</p><p>FORECAST CHANGES</p><p>   * The mean earnings estimate of analysts was unchanged in the last three months. </p><p>   * In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p><p>RECOMMENDATIONS</p><p>   * The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 3 \"hold\" and no \"sell\" or \"strong sell.\" </p><p>   * The average consensus recommendation for the advanced medical equipment &amp; technology peer group is also \"hold\"</p><p>Wall Street's median 12-month price target for Vicarious Surgical Inc is 10.00  This summary was machine generated from LSEG data November 12 at 11:27 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,</p><p>                                                MISSED</p><p>Sep. 30 2024      -2.55          -2.90          Missed</p><p>Jun. 30 2024      -2.77          -2.59          Beat</p><p>Mar. 31 2024      -2.85          -3.00          Missed</p><p>Dec. 31 2023      -3.75          -1.80          Beat</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RBOT","symbol_name":"Vicarious Surgical Inc.","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2483062095","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483062095","pubTimestamp":1731454104,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"* Vicarious Surgical Inc    reported a quarterly adjusted loss of $2.90 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-3.00.  ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"RBOT":"Vicarious Surgical Inc."},"translate_title":"Vicarious Surgical Inc报告截至9月30日的季度业绩-收益摘要","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RBOT":0.9},"content_text":"* Vicarious Surgical Inc    reported a quarterly adjusted loss of $2.90 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-3.00.  The mean expectation of four analysts for the quarter was for a loss of $2.55 per share. Wall Street expected results to range from $-2.80 to $-2.29 per share.   * Reported revenue was zero; analysts expected zero.    * Vicarious Surgical Inc's reported EPS for the quarter was a loss of $2.90.   * The company reported a quarterly loss of $17.09 million.   * Vicarious Surgical Inc shares had risen by 96.3% this quarter and gained 1.4% so far this year.FORECAST CHANGES   * The mean earnings estimate of analysts was unchanged in the last three months.    * In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.RECOMMENDATIONS   * The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 3 \"hold\" and no \"sell\" or \"strong sell.\"    * The average consensus recommendation for the advanced medical equipment & technology peer group is also \"hold\"Wall Street's median 12-month price target for Vicarious Surgical Inc is 10.00  This summary was machine generated from LSEG data November 12 at 11:27 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,                                                MISSEDSep. 30 2024      -2.55          -2.90          MissedJun. 30 2024      -2.77          -2.59          BeatMar. 31 2024      -2.85          -3.00          MissedDec. 31 2023      -3.75          -1.80          Beat","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}